Cox John, CEO of Dyne Therapeutics DYN, has filed 9 purchases and 7 sales on the open market. Over the past 12 months that comes to a net sale of $205.8K. The latest trade was on 06/16.

CJ

CJ

Cox John

CEO & President

Company

Dyne Therapeutics DYN

First filing

23/05/22

Trades

30 trades

Buys / sales

9 / 7

12-month net buying

−$205.8K

Last trade

06/16

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	06/16	06/17	2,683 sh	$18.33	$49,179.39	−0.7%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	05/13	05/14	3,311 sh	$18.36	$60,789.96	−0.9%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	03/05	03/06	2,732 sh	$14.90	$40,706.8	−0.7%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/12/05	25/12/05	2,662 sh	$20.72	$55,156.64	−1.3%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/09/05	25/09/09	2,640 sh	$13.41	$35,402.4	−1.3%
Dyne TherapeuticsDYN	Open-market buy	25/07/14	25/07/15	100,000 sh	$9.11	$911,000	+70.3%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/06/05	25/06/06	4,060 sh	$13.35	$54,201	−2.8%
Dyne TherapeuticsDYN	Open-market sale10b5-1 plan	25/03/05	25/03/07	4,061 sh	$11.83	$48,041.63	−2.7%
Dyne TherapeuticsDYN	Open-market buy	24/09/04	24/09/04	32,000 sh8 trades	$33.04avg.	$1,057,216	No record